MeSH term
Frequency | Condition_Probility | Animals | 21 | 0.0 |
Cell Line | 16 | 0.0 |
Chromatography, High Pressure Liquid | 8 | 0.0 |
Glucuronides/*metabolism | 10 | 62.0 |
Glucuronosyltransferase/*metabolism | 20 | 36.0 |
Humans | 85 | 0.0 |
In Vitro | 12 | 0.0 |
Isoenzymes/metabolism | 7 | 1.0 |
Microsomes, Liver/enzymology/metabolism | 3 | 4.0 |
Recombinant Proteins/metabolism | 11 | 0.0 |
Glucuronosyltransferase/genetics/*metabolism | 13 | 36.0 |
Isoenzymes/genetics/metabolism | 6 | 4.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 54 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Microsomes, Liver/enzymology/*metabolism | 6 | 7.0 |
Rats | 3 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Female | 11 | 0.0 |
Immunoblotting | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 28 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Glucuronides/metabolism | 10 | 23.0 |
Metabolic Detoxication, Drug | 4 | 4.0 |
Microsomes, Liver/*enzymology/metabolism | 3 | 10.0 |
Spectrum Analysis, Mass | 9 | 1.0 |
Stereoisomerism | 3 | 0.0 |
Substrate Specificity | 15 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Adult | 10 | 0.0 |
Aged | 9 | 0.0 |
Child, Preschool | 2 | 0.0 |
Glucuronosyltransferase/*genetics/metabolism | 5 | 20.0 |
Infant | 2 | 0.0 |
Microsomes, Liver/metabolism | 10 | 5.0 |
Middle Aged | 13 | 0.0 |
Kinetics | 22 | 0.0 |
Catalysis | 8 | 1.0 |
Anti-Inflammatory Agents, Non-Steroidal/*metabolism | 3 | 33.0 |
Glucuronosyltransferase/biosynthesis/genetics/*metabolism | 3 | 50.0 |
Isoenzymes/biosynthesis/genetics/metabolism | 3 | 10.0 |
Cells, Cultured | 6 | 0.0 |
Male | 16 | 0.0 |
Mice | 6 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Biotransformation | 6 | 1.0 |
*Escherichia coli Proteins | 2 | 0.0 |
Glucuronides/biosynthesis | 2 | 66.0 |
Hydroxylation | 3 | 0.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Narcotics/*metabolism | 3 | 30.0 |
Child | 3 | 0.0 |
Hymecromone/metabolism | 2 | 66.0 |
Adolescent | 3 | 0.0 |
Glucuronides/chemistry/*metabolism | 3 | 50.0 |
Microsomes/enzymology | 3 | 2.0 |
Microsomes, Liver/enzymology | 4 | 1.0 |
Molecular Structure | 3 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Chromatography, Liquid | 3 | 2.0 |
Cloning, Molecular | 5 | 0.0 |
Indicators and Reagents | 3 | 1.0 |
Alleles | 3 | 0.0 |
Androsterone/metabolism | 4 | 66.0 |
Gene Frequency | 2 | 0.0 |
Genotype | 6 | 0.0 |
Glucuronosyltransferase/*genetics | 6 | 5.0 |
Menthol/metabolism | 2 | 100.0 |
*Polymorphism, Genetic | 2 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Enzyme Stability | 2 | 1.0 |
Steroids/*metabolism | 3 | 7.0 |
Isoenzymes/genetics | 2 | 0.0 |
Glucuronosyltransferase/antagonists & inhibitors/*metabolism | 2 | 25.0 |
Carcinogens/*pharmacokinetics | 2 | 8.0 |
Hamsters | 4 | 0.0 |
Isoenzymes/genetics/*metabolism | 4 | 4.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
Xenobiotics/metabolism | 2 | 4.0 |
Blotting, Western | 4 | 0.0 |
Caco-2 Cells | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Enzyme Activation | 3 | 0.0 |
*Gene Expression Regulation, Enzymologic | 4 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Glucuronosyltransferase/*genetics/*metabolism | 2 | 28.0 |
Liver/enzymology | 3 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Liver/*enzymology | 4 | 0.0 |
Microsomes, Liver/*enzymology | 4 | 2.0 |
Androgens/*metabolism | 4 | 6.0 |
Glucuronates/*metabolism | 6 | 28.0 |
Enzyme Induction | 2 | 0.0 |
Pyridines/metabolism | 2 | 20.0 |
Comparative Study | 10 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Dogs | 2 | 0.0 |
Macaca fascicularis | 4 | 1.0 |
Microsomes, Liver/*metabolism | 4 | 2.0 |
Sequence Alignment | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Xenobiotics/*metabolism | 2 | 3.0 |
DNA, Complementary/genetics | 2 | 0.0 |
*Xanthones | 3 | 21.0 |
Morphine/*metabolism | 3 | 50.0 |
Treatment Outcome | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Polymorphism, Single Nucleotide/*genetics | 2 | 0.0 |
Microsomes/*metabolism | 2 | 4.0 |
Time Factors | 2 | 0.0 |
Cytochrome P-450 Enzyme System/metabolism | 2 | 0.0 |
Hydrolysis | 2 | 0.0 |
Transfection | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
